Loading...

Stephen Feig

Title(s)Clinical Professor, Radiological Sciences
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-6905
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Management of papillary lesions of the breast diagnosed by core biopsy: Need for an evidence-based standard of care. Breast J. 2019 09; 25(5):804-806. Feig SA. PMID: 31538383.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Can Radiologists Predict the Presence of Ductal Carcinoma In Situ and Invasive Breast Cancer? AJR Am J Roentgenol. 2017 Apr; 208(4):933-939. Aminololama-Shakeri S, Flowers CI, McLaren CE, Wisner DJ, de Guzman J, Campbell JE, Bassett LW, Ojeda-Fournier H, Gerlach K, Hargreaves J, Elson SL, Retallack H, Joe BN, Feig SA, Wells CJ. PMID: 28199152.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Inter-reader Variability in the Use of BI-RADS Descriptors for Suspicious Findings on Diagnostic Mammography: A Multi-institution Study of 10 Academic Radiologists. Acad Radiol. 2017 01; 24(1):60-66. Lee AY, Wisner DJ, Aminololama-Shakeri S, Arasu VA, Feig SA, Hargreaves J, Ojeda-Fournier H, Bassett LW, Wells CJ, De Guzman J, Flowers CI, Campbell JE, Elson SL, Retallack H, Joe BN. PMID: 27793579.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    4. Impact of Breast Density Legislation on Breast Cancer Risk Assessment and Supplemental Screening: A Survey of 110 Radiology Facilities. Breast J. 2016 Sep; 22(5):493-500. Nayak L, Miyake KK, Leung JW, Price ER, Liu YI, Joe BN, Sickles EA, Thomas WR, Lipson JA, Daniel BL, Hargreaves J, Brenner RJ, Bassett LW, Ojeda-Fournier H, Lindfors KK, Feig SA, Ikeda DM. PMID: 27296462.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    5. Personalized Screening for Breast Cancer: A Wolf in Sheep's Clothing? AJR Am J Roentgenol. 2015 Dec; 205(6):1365-71. Feig SA. PMID: 26348933.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Implications of Overdiagnosis: Impact on Screening Mammography Practices. Popul Health Manag. 2015 Sep; 18 Suppl 1:S3-11. Morris E, Feig SA, Drexler M, Lehman C. PMID: 26414384.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    7. Breast density evaluation using spectral mammography, radiologist reader assessment, and segmentation techniques: a retrospective study based on left and right breast comparison. Acad Radiol. 2015 Aug; 22(8):1052-9. Molloi S, Ding H, Feig S. PMID: 26031229.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Criteria for identifying radiologists with acceptable screening mammography interpretive performance on basis of multiple performance measures. AJR Am J Roentgenol. 2015 Apr; 204(4):W486-91. Miglioretti DL, Ichikawa L, Smith RA, Bassett LW, Feig SA, Monsees B, Parikh JR, Rosenberg RD, Sickles EA, Carney PA. PMID: 25794100.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    9. Overdiagnosis of breast cancer at screening is clinically insignificant. Acad Radiol. 2015 Aug; 22(8):961-6. Feig SA. PMID: 25797300.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    10. Postmortem validation of breast density using dual-energy mammography. Med Phys. 2014 Aug; 41(8):081917. Molloi S, Ducote JL, Ding H, Feig SA. PMID: 25086548.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Invited commentary: digital breast tomosynthesis-the road ahead. Radiographics. 2014 Jul-Aug; 34(4):E103-5. Feig SA. PMID: 25019449.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Screening mammography benefit controversies: sorting the evidence. Radiol Clin North Am. 2014 May; 52(3):455-80. Feig SA. PMID: 24792649.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    13. The California breast density information group: a collaborative response to the issues of breast density, breast cancer risk, and breast density notification legislation. Radiology. 2013 Dec; 269(3):887-92. Price ER, Hargreaves J, Lipson JA, Sickles EA, Brenner RJ, Lindfors KK, Joe BN, Leung JW, Feig SA, Bassett LW, Ojeda-Fournier H, Daniel BL, Kurian AW, Love E, Ryan L, Walgenbach DD, Ikeda DM. PMID: 24023072.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansPHPublic Health
    14. Diagnostic mammography: identifying minimally acceptable interpretive performance criteria. Radiology. 2013 May; 267(2):359-67. Carney PA, Parikh J, Sickles EA, Feig SA, Monsees B, Bassett LW, Smith RA, Rosenberg R, Ichikawa L, Wallace J, Tran K, Miglioretti DL. PMID: 23297329.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    15. Reply: To PMID 22528916. AJR Am J Roentgenol. 2013 Jan; 200(1):W98-9. Feig SA. PMID: 23379023.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    16. Impact of an educational intervention designed to reduce unnecessary recall during screening mammography. Acad Radiol. 2012 Sep; 19(9):1114-20. Carney PA, Abraham L, Cook A, Feig SA, Sickles EA, Miglioretti DL, Geller BM, Yankaskas BC, Elmore JG. PMID: 22727623.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. Number needed to screen: appropriate use of this new basis for screening mammography guidelines. AJR Am J Roentgenol. 2012 May; 198(5):1214-7. Feig SA. PMID: 22528916.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    18. Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer. 2012 Apr; 12(2):110-8. Kuzucan A, Chen JH, Bahri S, Mehta RS, Carpenter PM, Fwu PT, Yu HJ, Hsiang DJ, Lane KT, Butler JA, Feig SA, Su MY. PMID: 22444717.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    19. Use of clinical history affects accuracy of interpretive performance of screening mammography. J Clin Epidemiol. 2012 Feb; 65(2):219-30. Carney PA, Cook AJ, Miglioretti DL, Feig SA, Bowles EA, Geller BM, Kerlikowske K, Kettler M, Onega T, Elmore JG. PMID: 22000816.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology. 2011 Dec; 261(3):735-43. Chen JH, Bahri S, Mehta RS, Kuzucan A, Yu HJ, Carpenter PM, Feig SA, Lin M, Hsiang DJ, Lane KT, Butler JA, Nalcioglu O, Su MY. PMID: 21878615.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    21. Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI. Obstet Gynecol Clin North Am. 2011 Mar; 38(1):179-96, ix. Feig S. PMID: 21419333.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    22. Using a tailored web-based intervention to set goals to reduce unnecessary recall. Acad Radiol. 2011 Apr; 18(4):495-503. Carney PA, Bowles EJ, Sickles EA, Geller BM, Feig SA, Jackson S, Brown D, Cook A, Yankaskas BC, Miglioretti DL, Elmore JG. PMID: 21251856.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. Feasibility and satisfaction with a tailored web-based audit intervention for recalibrating radiologists' thresholds for conducting additional work-up. Acad Radiol. 2011 Mar; 18(3):369-76. Carney PA, Geller BM, Sickles EA, Miglioretti DL, Aiello Bowles EJ, Abraham L, Feig SA, Brown D, Cook AJ, Yankaskas BC, Elmore JG. PMID: 21193335.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    24. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening. Radiol Clin North Am. 2010 Sep; 48(5):879-91. Feig S. PMID: 20868891.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    25. Risk assessment, screening and prevention of breast cancer: A look at cost-effectiveness. Breast. 2010 Aug; 19(4):260-7. Lebovic GS, Hollingsworth A, Feig SA. PMID: 20399656.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    26. Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology. 2010 May; 255(2):354-61. Carney PA, Sickles EA, Monsees BS, Bassett LW, Brenner RJ, Feig SA, Smith RA, Rosenberg RD, Bogart TA, Browning S, Barry JW, Kelly MM, Tran KA, Miglioretti DL. PMID: 20413750.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic Health
    27. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010 Jan; 7(1):18-27. Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, D'Orsi C, Sickles E, Burhenne LW. PMID: 20129267.
      View in: PubMed   Mentions: 145     Fields:    Translation:HumansPHPublic Health
    28. Reproducibility of breast arterial calcium mass quantification using digital mammography. Acad Radiol. 2009 Mar; 16(3):275-82. Molloi S, Mehraien T, Iribarren C, Smith C, Ducote JL, Feig SA. PMID: 19201356.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    29. Ultrasound detection of nonpalpable mammographically occult malignancy. Can Assoc Radiol J. 2008 Apr; 59(2):70-6. Simpson WL, Hermann G, Rausch DR, Sherman J, Feig SA, Bleiweiss IJ, Jaffer S, Port A. PMID: 18533395.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    30. Auditing and benchmarks in screening and diagnostic mammography. Radiol Clin North Am. 2007 Sep; 45(5):791-800, vi. Feig SA. PMID: 17888769.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    31. Screening mammography: a successful public health initiative. Rev Panam Salud Publica. 2006 Aug-Sep; 20(2-3):125-33. Feig SA. PMID: 17199907.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    32. Screening mammography controversies: resolved, partly resolved, and unresolved. Breast J. 2005 Mar-Apr; 11 Suppl 1:S3-6. Feig SA. PMID: 15725113.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    33. Adverse effects of screening mammography. Radiol Clin North Am. 2004 Sep; 42(5):807-19, v. Feig SA. PMID: 15337417.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Re: Changes in breast cancer detection and mammography recall rates after the introduction of a computer-aided detection system. J Natl Cancer Inst. 2004 Aug 18; 96(16):1260-1; author reply 1261. Feig SA, Sickles EA, Evans WP, Linver MN. PMID: 15316065.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    35. Screening for cancer: when is it valid?--Lessons from the mammography experience. Radiology. 2003 Nov; 229(2):319-27. Kopans DB, Monsees B, Feig SA. PMID: 14595137.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    36. Survey of radiology residents: breast imaging training and attitudes. Radiology. 2003 Jun; 227(3):862-9. Bassett LW, Monsees BS, Smith RA, Wang L, Hooshi P, Farria DM, Sayre JW, Feig SA, Jackson VP. PMID: 12728182.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    37. How reliable is the evidence for screening mammography? Recent Results Cancer Res. 2003; 163:129-39; discussion 264-6. Feig SA. PMID: 12903849.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    38. Effect of service screening mammography on population mortality from breast carcinoma. Cancer. 2002 Aug 01; 95(3):451-7. Feig SA. PMID: 12209736.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    39. Image quality of screening mammography: effect on clinical outcome. AJR Am J Roentgenol. 2002 Apr; 178(4):805-7. Feig SA. PMID: 11906850.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Current status of screening mammography. Obstet Gynecol Clin North Am. 2002 Mar; 29(1):123-36. Feig SA. PMID: 11892862.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    41. Nonpalpable breast lesions: biopsy methods and patient management. Obstet Gynecol Clin North Am. 2002 Mar; 29(1):137-57. Schwartz GF, Feig SA. PMID: 11892863.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Ten criteria for effective screening. AJR Am J Roentgenol. 2002 Feb; 178(2):508-10. Kopans DB, Monsees B, Smith R, Feig S. PMID: 11804929.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health